Oxygen free radicals are known to produce cellular injury by peroxidation of phospholipids in the cell membrane. These free radicals might damage the endothelial cell and thus set the stage for atherosclerosis. The authors studied the effect of high-cholesterol diets on the genesis of atherosclerosis and lipid peroxidation products, malondialdehyde (MDA) in rabbits. The animals were divided into four groups each comprising 5 rabbits, on the basis of their diets. Group I, control diet; group II, cholesterol; group III, coconut oil; group IV, a mixture of cholesterol, coconut oil, and cholic acid. Rabbits were sacrificed five months after being on the respective diets. Blood samples were obtained for the measurements of total cholesterol, high density lipoprotein cholesterol (HDL- C), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), triglycerides, and MDA at the end of the protocol. The aortas were removed from different animals for the identification of athero sclerotic plaques. Plaques were detected in all the animals in group II and group IV. The serum total cholesterol, LDL-C, and VLDL-C were significantly higher in animals of group II and IV than in those of group I. The values for serum total cholesterol, HDL-C, LDL-C, and VLDL-C in group III were not signifi cantly different from those in group I. The blood MDA and serum triglycerides were also higher in animals of group II and IV than in those of group I. There were, however, no significant differences in these parameters in group III as compared with those in group I. This study showed that there was an increase in the lipid peroxidation product (MDA) in all those rabbits that had atheroscler otic changes in the aorta. This increase might be due to an increase in oxygen free radicals, which may be involved in the genesis and maintenance of choles terol-induced atherosclerosis.
Get full access to this article
View all access options for this article.
References
1.
Castelli WP, Garrison RJ, Wilson Pwf, et al: Incidence of coronary artery disease and lipoprotein cholesterol levels. JAMA256:2835-2838, 1986 .
2.
Fredrickson DS, Levy, RI: Familial hyperlipoproteinemias. In: The Metabolic Basis of Inherited Disease, ed. by Stanbury JB.New York: McGraw-Hill, 1972, pp 545-614.
3.
Constantinides P., Booth J., Carlson G.: Production of advanced cholesterol atherosclerosis in the rabbit. Arch Path70:712-724, 1960.
4.
Kannel WB, Dawber TR, Kagan A., et al: Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framington Study. Ann Intern Med55:33-50, 1961.
5.
Castelli WP: Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol4:5A-10A, 1988.
6.
Kannel WB, Castelli WP, Gordon T., et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med74:1-12, 1971.
7.
Ross R., Harker L.: Hyperlipidemia and atherosclerosis: Chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation. Science193:1094-1100, 1976.
8.
French JE: Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. Int Rev Exp Pathol5:253-353, 1966.
9.
Mustard JF, Packham MA: The role of blood and platelets in atherosclerosis and the complication of atherosclerosis. Thromb Diath Haemorrh33:444-456, 1975.
10.
Nelson E., Gertz SD, Forbes MS, et al: Endothelial lesions in the aorta of egg yolk-fed miniature swine: A study by scanning and transmission electron microscopy. Exp Mol Pathol25:208-220, 1976.
11.
Thomas WA, Florentin R., Nam S., et al: Proliferative phase of atherosclerosis in swine fed cholesterol . Arch Pathol86:621-643, 1968.
12.
Gordon D., Schwartz SM: Replication of arterial smooth muscle cells in hypertension and atherosclerosis . Am J Cardiol59:44A-48A, 1987.
13.
Stuart MJ, Gerrard JM, White JG: Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med302:6-10, 1980.
14.
Henriksson P., Stamberger M., Diezfalusy U.: Increased aortic thromboxane production in experimental atherosclerosis. Prostaglandins Leukotrienes Med29:71-77, 1987.
15.
Egan RW, Paxton J., Kuehl FA Jr: Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem251:7329-7335, 1976.
16.
Marnett LJ, Wlodawer P., Samuelsson B.: Co-oxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland. J Biol Chem250: 8510-8517, 1975.
17.
Panganamala RV, Sharma HM, Heikkila JC, et al: Role of hydroxyl radical scavangers, dimethyl sulfoxide, alcohol and methanol in the inhibition of prostaglandin biosynthesis. Prostaglandins11:599-607, 1976.
18.
Prasad K., Kalra J., Buchko G.: Acute hemorrhage and oxygen free radicals. Angiology39:1005-1013, 1988.
19.
McCord JM: Oxygen derived free radicals in postischemic tissue injury. N. Engl J Med312:159-163, 1985.
20.
Jolly SR, Kane WJ, Bailie MB, et al: Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res54:277-285, 1984.
21.
Hammond B., Kontos HA, Hess ML: Oxygen radicals in the adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage. Can J Physiol Pharmacol63:173-187, 1985.
22.
Mullane KM, Salmon JA, Kraemer R.: Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc46:2422-2433, 1987 .
23.
Hernandez LA , Grisham MB, Twohig B., et al: Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol253:H699-H703, 1987.
24.
Fantone JC, Ward PA: Role of oxygen derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol107:397-418, 1982.
25.
Lucchesi BR , Mullane KM: Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol26:201-224, 1986.
26.
Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest47:412-426, 1982.
27.
Meerson FZ, Kagon VE, Kozlov YP, et al: The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol77:465-485, 1982.
28.
Halliwell B., Gutteridge MC: Oxygen radicals and tissue damage. In: Advances in Studies on Heart Metabolism, ed. by Caldarera CM, Harris P.Bologna: CLVEB, 1982, pp 403-411.
29.
Yagi K.: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med15:212-216, 1976.
30.
Wahlefeld AW: Triglycerides determination after enzymatic hydrolysis. In: Methods in Enzymatic Analysis, ed. by Bergmeyer HU.New York: Verlag ChemieWeinheim/Academic Press Inc., 1974 , p 1831.
31.
Deeg R., Ziegenhorn J.: Kinetic enzymatic method for automated determination of serum total cholesterol . Clin Chem28:1574, 1982.
32.
Lopes-Virella MF, Stone P., Ellis S., et al: Cholesterol determination in high density lipoprotein separated by three different methods. Clin Chem23:882-884, 1977.
33.
Assmann G.: Lipiddiagnostik Leute. In: Lipoproteine und Herzinfarkt, ed. by Greten H, et al., Baden-Baden, W. Germany: Witzstrock-Verlag, 1979, p29.
34.
Wojcicki J. , Samochowiec L., Jaworska M., et al: A search for a model of experimental atherosclerosis: Comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol Pharm37:11-21, 1985.
35.
Bailey JM, Watson R., Bombard AT, et al: Anti-inflammatory drugs in experimental atherosclerosis. Part 5. Influence of cortisone acetate on short-term and long-term cholesterol fluxes in atherosclerotic aorta. Atherosclerosis51:299-306, 1984.
36.
Pearson TA, Malmros H., Dillman J., et al: Atherosclerosis in the hypercholesterolemic hare. Comparison of coronary artery lesions induced by dietary cholesterol in the hare and rabbit. Atherosclerosis63:125-135, 1987.
37.
Diccianni MB , Cardin AD, Britt AL, et al: Effect of sustained release of formulation of diltiazem on the development of atherosclerosis in cholesterol-fed rabbits . Atherosclerosis65:199-205, 1987.
38.
Sugano M., Nakashima Y., Tasaki H., et al: Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br J Exp Path69:515-523, 1988.
39.
Shattil SJ, Anaya-Galindo R., Bennet J., et al: Platelet hypersensitivity induced by cholesterol incorporation . J Clin Invest55:636-643, 1975.
40.
Henry RL: Platelet function. Seminars in Thrombosis andHemostasis4:93-122, 1977.
41.
Ruzicka T., Printz MP: Arachidonic acid metabolism in skin: A review. Rev Physiol Biochem Pharmacol100:121-160, 1984.
42.
Vanden Bosch H: Intracellular phospholipases A. Biochim Biophys Acta604:191-246, 1980.
43.
Shattil SJ, Cooper RA: Role of membrane lipid composition, organization and fluidity in human platelet function. Prog Hemost Thromb4:59-86, 1978.
44.
Ford-Hutchinson AW, Bray MA, Doig MV, et al: Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature286:264-267, 1980.
45.
Kontos HA, Wei EP, Povlishwck JT, et al: Cerebral arteriolar damage by arachidonic acid and prostaglandin G2. Science209:1242-1245, 1980 .
